SOLU-MEDROL

Product NDC
50090-0271
Requested package NDC
50090-0271-1
11-digit product format
500900271
Labeler code
50090
Product ID
50090-0271_6570e7e8-b248-4375-b452-2f683d9f488b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
methylprednisolone sodium succinate
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
A-S Medication Solutions
Application
NDA011856
Marketing category
NDA
Marketing start
1959-04-02
Substance
METHYLPREDNISOLONE SODIUM SUCCINATE
Active strength
125 mg/2mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage50090-027150090-0271-1DDiscontinued by firm2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N011856-003SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N011856-004SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N011856-005SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N011856-006SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982
N011856-007SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-productTE code
N011856-003AP
N011856-004AP
N011856-005AP
N011856-006AP
N011856-007AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 205 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-27011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-2731067a03dcf5…
2025-08-23 18:47 UTC2025-08N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19826a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-276a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-27fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-27b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 198203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-2703ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19822680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-272680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-003SOLU-MEDROLEQ 40MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-004SOLU-MEDROLEQ 125MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-005SOLU-MEDROLEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-006SOLU-MEDROLEQ 1GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19825bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-007SOLU-MEDROLEQ 2GM BASE/VIALINJECTABLE / INJECTIONAPRLD, RS1985-02-275bbf6a4d5a75…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 6 · 205 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02N011856-003AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-004AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-005AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-006AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02N011856-007AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-003AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-004AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-005AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-006AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N011856-007AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08N011856-003AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-004AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-005AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-006AP16a471c1ec25d…
2025-08-23 18:47 UTC2025-08N011856-007AP16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-003AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-004AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-005AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-006AP1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N011856-007AP1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-003AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-004AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-005AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-006AP1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N011856-007AP1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-003AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-004AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-005AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-006AP103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N011856-007AP103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-003AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-004AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-005AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-006AP12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N011856-007AP12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-003AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-004AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-005AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-006AP15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N011856-007AP15bbf6a4d5a75…

Additional Listing Data#

Finished product
Yes
Brand name base
SOLU-MEDROL
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
METHYLPREDNISOLONE SODIUM SUCCINATE125 mg/2mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
LEC9GKY20KInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
1743704Internal RxNorm lookup
1743707Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b3918abe-5cd1-b0ce-abd7-2dd6732cde26Product name520260128
e1637c7c-52c4-49a3-b36b-61be755aab29Product name420230717
9eb3e96d-a1d4-4de3-aa3d-a629eea44815Product name420220316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
50090-0271-02023-03-06SOLU-MEDROL
50090-0271-02023-03-06SOLU-MEDROL
50090-0271-12023-03-06SOLU-MEDROL
50090-0271-12023-03-06SOLU-MEDROL
50090-0271-02023-01-30SOLU-MEDROL
50090-0271-02023-01-30SOLU-MEDROL
50090-0271-12023-01-30SOLU-MEDROL
50090-0271-12023-01-30SOLU-MEDROL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50090-0271-0SOLU-MEDROL2 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION231
50090-0271-1SOLU-MEDROL25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION2531
50090-0271-1SOLU-MEDROL2 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION231

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
50090-0271-0EA - Each50090-0271e0e94afb-3d63-4366-b45d-bd012b91b7d612018-08-13
50090-0271-1EA - Each50090-0271708bbff4-0ea4-4958-9a14-634ed5bfd54912018-08-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50090-0271SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [A-S MEDICATION SOLUTIONS]31Current NDC, Legacy NDC, 3 package rows20230307_8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 18 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATESportpharm LLC0cb0ba76-067f-46c4-a5d8-b585d5ecafe32026-07-23Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
Solu-MedrolMETHYLPREDNISOLONE SODIUM SUCCINATECardinal Health 107, LLC68ef8ec4-16de-4a8c-8696-b093596603802026-07-17Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEPharmacia & Upjohn Company LLC7271310c-7764-4812-aa30-a5e90987c7a92026-06-25Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
Solu-MedrolMETHYLPREDNISOLONE SODIUM SUCCINATEHenry Schein, Inc.ea2f9b6f-2375-40a6-8b97-b607b9f3ac632026-06-04Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEA-S Medication Solutions8e5997ed-f4a5-43f7-abbd-c8e2219fe0e92026-05-29Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
ndc (package): 50090-0271-1
ndc (product): 50090-0271
ndc11 (package): 50090027101
Solu-MedrolMETHYLPREDNISOLONE SODIUM SUCCINATECardinal Health 107, LLC2af28649-2553-4bcc-9cb1-c73f7cec76d52026-05-20Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
Solu-MedrolMETHYLPREDNISOLONE SODIUM SUCCINATEHenry Schein, Inc.decceb81-e922-4b72-a278-3ed80f4adb042026-03-18Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEREMEDYREPACK INC.1d5ef347-2e9a-432f-9a88-a7c4ba3002672026-01-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
Solu-MedrolMETHYLPREDNISOLONE SODIUM SUCCINATECardinal Health 107, LLC7e38b09c-da41-4ee3-8f99-812d3276d5512025-12-19Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEProPharma Distribution42df21df-9284-4505-e063-6294a90a70242025-12-18Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEPharmacia & Upjohn Company LLCcd99be87-c8d9-48d6-a8e5-e081052e3f192025-12-02Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEProPharma Distribution38698075-ac58-b5a4-e063-6294a90a78482025-07-18Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINATSOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINATHF Acquisition Co LLC, DBA HealthFirst99b3c99a-79d5-6c54-e053-2a95a90a28bc2025-01-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLSOLU-MEDROLHF Acquisition Co. LLC, DBA HealthFirst74e5060c-8426-1b77-e053-2a91aa0a1f132024-02-22Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLSOLU-MEDROLHF Acquisition Co. LLC, DBA HealthFirst74e448ed-f4b4-8d09-e053-2991aa0a75002024-01-29Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEMedical Purchasing Solutions, LLC6a26a977-95dd-cdae-e053-2a91aa0a8b0a2023-05-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEMedical Purchasing Solutions, LLCdd2bfa31-9eae-2baa-e053-2a95a90a9db72023-05-23Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856
SOLU-MEDROLMETHYLPREDNISOLONE SODIUM SUCCINATEMedical Purchasing Solutions, LLCb635e21b-d68d-f60b-e053-2995a90a0f462023-05-08Warnings, Adverse reactionsExact identifier
application applno (NDA): 011856
application number: NDA011856

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1743704methylPREDNISolone sodium succinate 125 MG InjectionPSN8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743707SOLU-Medrol 125 MG InjectionPSN8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743707methylprednisolone 125 MG Injection [Solu-Medrol]SBD8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743704methylprednisolone 125 MG InjectionSCD8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743704methylprednisolone (as methylprednisolone sodium succinate) 125 MG InjectionSY8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743707Solu-Medrol (as methylprednisolone sodium succinate) 125 MG InjectionSY8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933
1743707Solu-Medrol 125 MG InjectionSY8e5997ed-f4a5-43f7-abbd-c8e2219fe0e933

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
50090-0271-15009002710125 VIAL in 1 CARTON (50090-0271-1) / 2 mL in 1 VIAL25 vial2015-07-210000-00-00NoNoCurrent